Opipramol (Insidon - Geigy) is a dibenzazepine derivative which structurally resembles both perphenazine and imipramine. It is described as ‘an anti-depressant with a pronounced sedative effect.’ Its thymoleptic activity is regarded as insufficient for the treatment of severe depression but ‘eminently suitable for the treatment of those patients whose complaints are difficult to define objectively and who experience a mixed complex of symptoms arising from the emotional problems associated with their everyday lives.’ This seems to exclude only the seriously ill and the euphoric.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.